Chronic low back pain affects millions of people worldwide and often limits the ability to move, work and live actively. Many existing treatments provide temporary relief, while rehabilitation can stall when protective reflex patterns persist and compensation becomes the new baseline. Qmedic and the Flemish digital development partner Codevid are working with support from CrossRoads Flanders-Netherlands to develop a connected therapy platform that supports clinic-guided rehabilitation and home follow-up.
In as many as 85% of patients with chronic low back pain, the exact cause remains unknown. This makes chronic low back pain a complex functional problem, in which pain, movement, muscle tone and protective reflex activity can reinforce each other over time. Many treatments focus mainly on symptom management, while the protective motor state itself may remain unchanged.
Qmedic has developed Liveve SSRT, a non-invasive neuromodulation technology that analyzes the nervous system’s local response to specific pulse patterns. Based on this measured response, SSRT is designed to influence segmental reflex circuits and create a short functional reset window. This helps the body step out of persistent protective motor control and allows rehabilitation to become effective again. Each treatment is tailored to the patient’s unique neurological response.
To achieve this, Qmedic is now working together with Codevid. In this project, we combine Qmedic's existing SSRT (Selective Synapse Reset) technology with new data models and AI supported workflows. The project includes the development of a device for home-based follow-up treatment and measurements, as well as a platform that integrates therapy data, patient-reported progress and clinical workflow information. Based on real-time insights, therapists can monitor progress more closely and adjust the treatment pathway where needed.
Chronic low back pain affects 1 in 20 people and places a heavy burden on patients and healthcare systems. In the Netherlands and Belgium, the average annual burden is estimated at €18,000 per patient, including treatment costs and wider social costs. A connected home solution like this offers more than pain relief: it can support a more scalable rehabilitation pathway, reduce pressure on healthcare resources and improve quality of life. By combining home follow-up, cloud-based data storage and AI-supported analysis, the project creates a foundation for personalised treatment guidance and contributes to the digital transformation of healthcare.
*Crossroads is a cross-border grant facility within the European programme Interreg Flanders-Netherlands. Crossroads aims to stimulate sustainable cross-border cooperation on promising innovation projects between SMEs in Flanders and the southern Netherlands.
